Fujifilm Sonosite Inc.

Fujifilm Sonosite Inc., a foreign-owned manufacturer of point-of-care ultrasound systems and portable medical imaging equipment headquartered in Bothell, Washington, competes as a prime contractor on full-and-open federal healthcare procurement without set-aside designation, delivering specialized diagnostic imaging platforms through multiple master IDIQ vehicles serving the Department of Veterans Affairs, Defense Logistics Agency, military treatment facilities, and federal correctional systems.

Fujifilm Sonosite is a subsidiary of Fujifilm Holdings America Corp and operates as a for-profit medical technology manufacturer with a $1.41 billion combined potential value across 5,331 federal awards since 1999. The company's federal contract portfolio is heavily concentrated in medical equipment supply: approximately 68% of awards fall under medical, dental, and hospital equipment merchant wholesaler NAICS categories (3,209 awards), with an additional 856 awards in surgical and medical instrument manufacturing and 540 in irradiation apparatus manufacturing. Procurement Service Classification codes mirror this concentration, with 3,763 awards for imaging equipment and supplies and 1,271 for medical and surgical instruments. Fujifilm Sonosite competes in full-and-open (non-set-aside) channels exclusively across its recent federal footprint; no SBA designations or small business set-asides characterize its work.

Customer concentration is extreme: the Defense Logistics Agency Troop Support Medical division anchors 2,461 awards worth $1.18 billion in combined potential value—84% of all potential value and 46% of all awards. The Department of Veterans Affairs National Acquisition Center places 624 awards worth $58.9 million, while DLA-VA NAC Radiology and Imaging Systems Program as a parent vehicle accounts for 736 task orders valued at $63.5 million. The top five funding agencies account for 76% of awards by count but 92% by potential value, indicating that DLA-Medical Supply Chain dominates both volume and dollar magnitude. Recent activity shows 269 awards in 2025 and 71 in 2026 (partial year), suggesting sustained but moderately declining throughput compared to the 289–272 annual pace of 2022–2023.

Capability framing: Fujifilm Sonosite delivers portable ultrasound platforms (Sonosite LX, PX, ST, Edge II series) configured for acute care, emergency medicine, anesthesia, perioperative care, obstetric/gynecological, musculoskeletal evaluation, and procedural guidance applications, along with associated transducers, accessories, and service components. Representative awards span $2,655 (ECG module, December 2025) to $873,195 (XR US system package, Portland VA, March 2026). Recent delivery orders under the DLA Medical Capital Equipment Program address specialty configurations: Sonosite LX family medicine, perioperative anesthesia, OB/GYN, acute care, and MSK evaluation systems ranging from $44,715 to $130,800 per order. The DLA-VA NAC Radiology and Imaging Systems Program drives the second-largest volume, with orders for VA medical center equipment consolidations, upgrades, and administrative corrections at individual VA locations (Aurora, San Francisco, Minneapolis, Pittsburgh, Los Angeles, Charlotte, and dozens of others), typically $50,000–$250,000 per delivery order.

Vehicle position: The DLA Medical Capital Equipment Program anchors 2,527 task orders valued at $167.9 million, making it by far Fujifilm Sonosite's dominant vehicle. The DLA-VA NAC Radiology and Imaging Systems Program (jointly administered by Defense Logistics Agency and Veterans Affairs) carries 736 task orders worth $63.5 million. Federal Supply Schedule V797P4529A supports 666 task orders ($25.4 million), while Indefinite Delivery Contract V797P6031B (537 task orders, $20.6 million) and SP020002D8320 (175 task orders, $25.7 million) round out the top five vehicles. Fujifilm Sonosite's participation across these multiple IDIQ vehicles positions the company to respond to delivery orders across the federal healthcare system without recompete risk for the underlying master contracts.

Activity trajectory: Awards have declined modestly from 289 in 2022 to 71 in 2026 (partial), with 2025 showing 269 orders—a 7% year-over-year contraction from 2024's 239 but recovering from 2023's 272. Over the past twenty-four months, 41 awards worth $5.3 million carry ultimate completion dates inside the recompete window, representing minimal recompete exposure relative to the vendor's $1.41 billion total portfolio. The low concentration of near-term completions suggests stable contract renewal or long-term order patterns.

Subcontract footprint: Fujifilm Sonosite operates exclusively as a prime contractor; the source identifies only one sub-award (Arcticom LLC in support of Air National Guard CBRNE mission, April 2024) across the entire 5,331-award portfolio, indicating a 0% sub-award rate and no material subcontracting relationships.

Corporate structure: Fujifilm Sonosite is a subsidiary of Fujifilm Holdings America Corp, with named subsidiaries including Cardiodynamics International Corporation and Sonosite LTD. This parent-child relationship anchors the company within a broader Fujifilm corporate footprint capable of supporting integrated medical device supply chains. Foreign ownership (parent company structure) does not restrict market access in federal procurement, and Fujifilm Sonosite competes openly on civilian and military medical supply vehicles without restriction.